Celina M. Scally Sells 1,278 Shares of Apria, Inc. (NYSE:APR) Stock

Apria, Inc. (NYSE:APR) SVP Celina M. Scally sold 1,278 shares of the company’s stock in a transaction that occurred on Wednesday, October 13th. The shares were sold at an average price of $32.35, for a total value of $41,343.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Apria stock traded down $0.02 during mid-day trading on Wednesday, reaching $32.41. 186,567 shares of the company were exchanged, compared to its average volume of 319,229. The company has a fifty day simple moving average of $35.46 and a 200-day simple moving average of $31.20. Apria, Inc. has a 12 month low of $20.07 and a 12 month high of $40.00. The company has a debt-to-equity ratio of 215.95, a current ratio of 1.21 and a quick ratio of 1.18. The firm has a market cap of $1.14 billion and a PE ratio of 0.70.

Apria (NYSE:APR) last posted its quarterly earnings data on Thursday, August 5th. The company reported $0.54 EPS for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.17. The company had revenue of $286.28 million for the quarter, compared to the consensus estimate of $280.18 million. Sell-side analysts anticipate that Apria, Inc. will post 1.63 earnings per share for the current year.

Several analysts have issued reports on APR shares. Citigroup upped their price objective on Apria from $33.00 to $38.00 and gave the company a “buy” rating in a research note on Friday, August 6th. The Goldman Sachs Group lowered Apria from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $32.00 to $29.00 in a research note on Monday, July 19th. began coverage on Apria in a research note on Wednesday, June 30th. They set a “buy” rating and a $33.00 target price on the stock. Zacks Investment Research lowered Apria from a “buy” rating to a “hold” rating in a research note on Wednesday, October 6th. Finally, Piper Sandler increased their target price on Apria from $33.00 to $35.00 and gave the stock an “overweight” rating in a research note on Friday, August 6th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $31.86.

A number of institutional investors have recently bought and sold shares of the business. Blackstone Group Inc. bought a new position in Apria during the 1st quarter worth $676,242,000. Bank of New York Mellon Corp increased its stake in Apria by 24.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,628,284 shares of the company’s stock worth $45,593,000 after acquiring an additional 320,425 shares during the period. American Century Companies Inc. bought a new position in Apria during the 2nd quarter worth $33,765,000. Deerfield Management Company L.P. Series C bought a new position in Apria during the 1st quarter worth $33,516,000. Finally, Burgundy Asset Management Ltd. bought a new position in Apria during the 1st quarter worth $28,031,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.

About Apria

Apria, Inc provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products.

Featured Story: What are the disadvantages of after-hours trading?

Insider Buying and Selling by Quarter for Apria (NYSE:APR)

Receive News & Ratings for Apria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apria and related companies with MarketBeat.com's FREE daily email newsletter.